Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1)

被引：39

作者：

Nantermet, PG ^{[1
]}

Barrow, JC

Lundell, GF

Pellicore, JM

Rittle, KE

Young, M

Freidinger, RM

Connolly, TM

Condra, C

Karczewski, J

Bednar, RA

Gaul, SL

Gould, RJ

Prendergast, K

Selnick, HG

机构：

[1] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA

[2] Merck Res Labs, Dept Pharmacol, West Point, PA 19486 USA

[3] Merck Res Labs, Dept Mol Design & Divers, West Point, PA 19486 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2002年 / 12卷 / 03期

关键词：

D O I：

10.1016/S0960-894X(01)00745-4

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The synthesis and biological evaluation of a series of nonpeptidic small molecule antagonists of the human platelet thrombin receptor (PAR-1) are described. Optimization of the 5-amino-3-arylisoxazole lead resulted in an approximate 100-fold increase in potency. The most potent of these compounds (54) inhibits platelet activation with IC50S of 90 nM against the thrombin receptor agonist peptide (TRAP) and 510 nM against thrombin as the agonist. Further, antagonist 54 fully blocks platelet aggregation stimulated by 1 nM thrombin for 10 min. (C) 2002 Published by Elsevier Science Ltd.

引用

页码：319 / 323

页数：5

共 50 条

[1] Discovery of a non-peptide small molecule antagonist of the human platelet thrombin receptor (PAR-1).
Selnick, H
Nantermet, PG
Rittle, K
Lundell, GF
Barrow, JC
Glass, K
Young, M
Pellicore, JM
Ngo, PL
Freidinger, R
Prendergast, K
Gould, R
Condra, C
Karczewski, J
Connolly, T
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U540 - U540
[2] Non-peptidic small molecule antagonists of the human platelet thrombin receptor (PAR-1).
Nantermet, PG
Selnick, HG
Barrow, JC
Lundell, GF
Rittle, KE
Glass, KL
Young, M
Pellicore, JM
Ngo, PL
Freidinger, RM
Prendergast, K
Condra, C
Karczewski, J
Gould, R
Connolly, TM
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U60 - U60
[3] A small-molecule thrombin receptor (PAR-1) antagonist blocks thrombosis in non-human primates.
Andrade-Gordon, P
Derian, CK
Damiano, BP
D'Andrea, MR
Addo, MF
Darrow, AL
Nedelman, M
Zhang, HC
Maryanoff, BE
[J]. BLOOD, 2001, 98 (11) : 44A - 44A
[4] Thrombin receptor antagonists; Recent advances in PAR-1 antagonist development
Anderluh, M
Dolenc, MS
[J]. CURRENT MEDICINAL CHEMISTRY, 2002, 9 (13) : 1229 - 1250
[5] Role and regulation of the thrombin receptor (PAR-1) in human melanoma
Carmen Tellez
Menashe Bar-Eli
[J]. Oncogene, 2003, 22 : 3130 - 3137
[6] Role and regulation of the thrombin receptor (PAR-1) in human melanoma
Tellez, C
Bar-Eli, M
[J]. ONCOGENE, 2003, 22 (20) : 3130 - 3137
[7] Potential therapeutic applications of a selective thrombin receptor (Par-1) antagonist.
Derian, CK
Johnson, RW
Andrade-Gordon, P
Maryanoff, BE
Zhang, HC
Addo, MF
Cheung, WM
Damiano, BP
D'Andrea, MR
Darrow, AL
De Garavilla, L
Eckardt, AJ
Giardino, E
[J]. CIRCULATION, 2000, 102 (18) : 301 - 301
[8] Improved synthesis of the PAR-1 thrombin receptor antagonist RWJ-58259
Valdivielso, Angel M.
Teresa Garcia-Lopez, M.
Herranz, Rosario
[J]. ARKIVOC, 2008, : 287 - 294
[9] Discovery and optimization of potent orally active small molecular thrombin receptor PAR-1 antagonists.
Kawahara, T
Suzuki, S
Kogushi, M
Matsuoka, T
Kobayashi, H
Kajiwara, A
Hishinuma, I
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U215 - U215
[10] Improved synthesis of the PAR-1 thrombin receptor antagonist RWJ-58259
Valdivielso, Angel M.
Teresa Garcia-Lopez, M.
Herranz, Rosario
[J]. ARKIVOC, 2008, : S1 - S4

← 1 2 3 4 5 →